Approximately 40 participants will be enrolled in this study at the Greenville Health System. Participation is anticipated to last up to 17 weeks and will include a 4 week screening period, randomization (Visit 1) and office visits at the study doctor's office once every week for up to 12 weeks (Visit 2 - Visit 12). All participants will receive the standard of care wound treatment during the 4 week screening period. The treatment plan outlined in treatment group 1 or treatment group 2 will be followed after randomization.